NDC 70625-113

Lincomycin

Lincomycin

Lincomycin is a Intramuscular; Intravenous; Subconjunctival Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Praxgen Pharmaceuticals Llc. The primary component is Lincomycin Hydrochloride.

Product ID70625-113_be75b2cd-1337-6d22-e053-2995a90a23d2
NDC70625-113
Product TypeHuman Prescription Drug
Proprietary NameLincomycin
Generic NameLincomycin
Dosage FormInjection, Solution
Route of AdministrationINTRAMUSCULAR; INTRAVENOUS; SUBCONJUNCTIVAL
Marketing Start Date2021-03-30
Marketing CategoryANDA /
Application NumberANDA212770
Labeler NamePraxgen Pharmaceuticals LLC
Substance NameLINCOMYCIN HYDROCHLORIDE
Active Ingredient Strength300 mg/mL
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 70625-113-01

1 VIAL in 1 CARTON (70625-113-01) > 10 mL in 1 VIAL
Marketing Start Date2021-03-30
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Lincomycin" or generic name "Lincomycin"

NDCBrand NameGeneric Name
0404-9901LINCOMYCINlincomycin hydrochloride
39822-0350Lincomycinlincomycin hydrochloride
39822-0353Lincomycinlincomycin hydrochloride
42571-374LincomycinLincomycin
50090-4533Lincomycinlincomycin hydrochloride
52584-353LINCOMYCINlincomycin hydrochloride
70436-034lincomycinlincomycin
70436-035lincomycinlincomycin
70625-113Lincomycinlincomycin

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.